Bill Text: MN HF2932 | 2013-2014 | 88th Legislature | Engrossed

---

Bill Title: Health and human services committees and task forces established and modified, and prescription monitoring program changed.

Spectrum: Moderate Partisan Bill (Democrat 15-3)

Status: (Introduced - Dead) 2014-03-26 - Committee report, to adopt as amended and re-refer to Health and Human Services Policy [HF2932 Detail]

Download: Minnesota-2013-HF2932-Engrossed.html

---

A bill for an act

relating to governmental operations; establishing and modifying health and
human services committees and task forces; changing the prescription monitoring
program;amending Minnesota Statutes 2012, sections 152.126, as amended;
214.32.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

    Section 1. Minnesota Statutes 2012, section 152.126, as amended by Laws 2013,
chapter 113, article 3, section 3, is amended to read:
152.126 CONTROLLED SUBSTANCES PRESCRIPTION ELECTRONIC
REPORTING SYSTEM PRESCRIPTION MONITORING PROGRAM.
    Subdivision 1. Definitions. (a) For purposes of this section, the terms defined in
this subdivision have the meanings given.
    (a) (b) "Board" means the Minnesota State Board of Pharmacy established under
chapter 151.
    (b) (c) "Controlled substances" means those substances listed in section 152.02,
subdivisions 3 to 5 6, and those substances defined by the board pursuant to section
152.02, subdivisions 7 , 8, and 12. For the purposes of this section, controlled substances
includes tramadol and butalbital.
    (c) (d) "Dispense" or "dispensing" has the meaning given in section 151.01,
subdivision 30 . Dispensing does not include the direct administering of a controlled
substance to a patient by a licensed health care professional.
    (d) (e) "Dispenser" means a person authorized by law to dispense a controlled
substance, pursuant to a valid prescription. For the purposes of this section, a dispenser does
not include a licensed hospital pharmacy that distributes controlled substances for inpatient
hospital care or a veterinarian who is dispensing prescriptions under section 156.18.
    (e) (f) "Prescriber" means a licensed health care professional who is authorized to
prescribe a controlled substance under section 152.12, subdivision 1 or 2.
    (f) (g) "Prescription" has the meaning given in section 151.01, subdivision 16.
    Subd. 1a. Treatment of intractable pain. This section is not intended to limit or
interfere with the legitimate prescribing of controlled substances for pain. No prescriber
shall be subject to disciplinary action by a health-related licensing board for prescribing a
controlled substance according to the provisions of section 152.125.
    Subd. 2. Prescription electronic reporting system. (a) The board shall establish
by January 1, 2010, an electronic system for reporting the information required under
subdivision 4 for all controlled substances dispensed within the state.
    (b) The board may contract with a vendor for the purpose of obtaining technical
assistance in the design, implementation, operation, and maintenance of the electronic
reporting system.
    Subd. 3. Prescription Electronic Reporting Monitoring Program Advisory
Committee Task Force. (a) The board shall convene shall appoint an advisory committee.
The committee must include task force consisting of at least one representative of:
    (1) the Department of Health;
    (2) the Department of Human Services;
    (3) each health-related licensing board that licenses prescribers;
    (4) a professional medical association, which may include an association of pain
management and chemical dependency specialists;
    (5) a professional pharmacy association;
    (6) a professional nursing association;
    (7) a professional dental association;
    (8) a consumer privacy or security advocate; and
    (9) a consumer or patient rights organization.
    (b) The advisory committee task force shall advise the board on the development and
operation of the electronic reporting system prescription monitoring program, including,
but not limited to:
    (1) technical standards for electronic prescription drug reporting;
    (2) proper analysis and interpretation of prescription monitoring data; and
    (3) an evaluation process for the program.
(c) The task force is governed by section 15.059.
    Subd. 4. Reporting requirements; notice. (a) Each dispenser must submit the
following data to the board or its designated vendor, subject to the notice required under
paragraph (d):
    (1) name of the prescriber;
    (2) national provider identifier of the prescriber;
    (3) name of the dispenser;
    (4) national provider identifier of the dispenser;
    (5) prescription number;
    (6) name of the patient for whom the prescription was written;
    (7) address of the patient for whom the prescription was written;
    (8) date of birth of the patient for whom the prescription was written;
    (9) date the prescription was written;
    (10) date the prescription was filled;
    (11) name and strength of the controlled substance;
    (12) quantity of controlled substance prescribed;
    (13) quantity of controlled substance dispensed; and
    (14) number of days supply.
    (b) The dispenser must submit the required information by a procedure and in a
format established by the board. The board may allow dispensers to omit data listed in this
subdivision or may require the submission of data not listed in this subdivision provided
the omission or submission is necessary for the purpose of complying with the electronic
reporting or data transmission standards of the American Society for Automation in
Pharmacy, the National Council on Prescription Drug Programs, or other relevant national
standard-setting body.
    (c) A dispenser is not required to submit this data for those controlled substance
prescriptions dispensed for:
    (1) individuals residing in licensed skilled nursing or intermediate care facilities;
    (2) individuals receiving assisted living services under chapter 144G or through a
medical assistance home and community-based waiver;
    (3) individuals receiving medication intravenously;
    (4) individuals receiving hospice and other palliative or end-of-life care; and
    (5) individuals receiving services from a home care provider regulated under chapter
144A.
    (1) individuals residing in a health care facility as defined in section 151.58,
subdivision 2, paragraph (b), when a drug is distributed through the use of an automated
drug distribution system according to section 151.58; and
    (2) individuals receiving a drug sample that was packaged by a manufacturer and
provided to the dispenser for dispensing as a professional sample pursuant to Code of
Federal Regulations, title 21, section 203, subpart D.
    (d) A dispenser must not submit data under this subdivision unless provide to the
patient for whom the prescription was written a conspicuous notice of the reporting
requirements of this section is given to the patient for whom the prescription was written
and notice that the information may be used for program administration purposes.
    Subd. 5. Use of data by board. (a) The board shall develop and maintain a database
of the data reported under subdivision 4. The board shall maintain data that could identify
an individual prescriber or dispenser in encrypted form. Except as otherwise allowed
under subdivision 6, the database may be used by permissible users identified under
subdivision 6 for the identification of:
    (1) individuals receiving prescriptions for controlled substances from prescribers
who subsequently obtain controlled substances from dispensers in quantities or with a
frequency inconsistent with generally recognized standards of use for those controlled
substances, including standards accepted by national and international pain management
associations; and
    (2) individuals presenting forged or otherwise false or altered prescriptions for
controlled substances to dispensers.
    (b) No permissible user identified under subdivision 6 may access the database
for the sole purpose of identifying prescribers of controlled substances for unusual or
excessive prescribing patterns without a valid search warrant or court order.
    (c) No personnel of a state or federal occupational licensing board or agency may
access the database for the purpose of obtaining information to be used to initiate or
substantiate a disciplinary action against a prescriber.
    (d) Data reported under subdivision 4 shall be retained by the board in the database
for a 12-month period, and shall be removed from the database no later than 12 months
from the last day of the month during which the data was received. made available to
permissible users for a 12-month period beginning the day the data was received and
ending 12 months from the last day of the month in which the data was received, except
that permissible users defined in subdivision 6, paragraph (b), clauses (5) and (6), may
use all data collected under this section for the purposes of administering, operating,
and maintaining the prescription monitoring program and conducting trend analyses
and other studies necessary to evaluate the effectiveness of the program. Data retained
beyond 12 months must be de-identified.
(e) The board shall not retain data reported under subdivision 4 for a period longer
than five years from the date the data was received.
    Subd. 6. Access to reporting system data. (a) Except as indicated in this
subdivision, the data submitted to the board under subdivision 4 is private data on
individuals as defined in section 13.02, subdivision 12, and not subject to public disclosure.
    (b) Except as specified in subdivision 5, the following persons shall be considered
permissible users and may access the data submitted under subdivision 4 in the same or
similar manner, and for the same or similar purposes, as those persons who are authorized
to access similar private data on individuals under federal and state law:
    (1) a prescriber or an agent or employee of the prescriber to whom the prescriber has
delegated the task of accessing the data, to the extent the information relates specifically to
a current patient, to whom the prescriber is:
    (i) prescribing or considering prescribing any controlled substance;
    (ii) providing emergency medical treatment for which access to the data may be
necessary; or
    (iii) providing other medical treatment for which access to the data may be necessary
and the patient has consented to access to the submitted data, and with the provision that
the prescriber remains responsible for the use or misuse of data accessed by a delegated
agent or employee;
    (2) a dispenser or an agent or employee of the dispenser to whom the dispenser has
delegated the task of accessing the data, to the extent the information relates specifically
to a current patient to whom that dispenser is dispensing or considering dispensing any
controlled substance and with the provision that the dispenser remains responsible for the
use or misuse of data accessed by a delegated agent or employee;
    (3) an individual who is the recipient of a controlled substance prescription for
which data was submitted under subdivision 4, or a guardian of the individual, parent or
guardian of a minor, or health care agent of the individual acting under a health care
directive under chapter 145C;
    (4) personnel of the board specifically assigned to conduct a bona fide investigation
of a specific licensee;
    (5) personnel of the board engaged in the collection, review, and analysis
of controlled substance prescription information as part of the assigned duties and
responsibilities under this section;
    (6) authorized personnel of a vendor under contract with the board state of
Minnesota who are engaged in the design, implementation, operation, and maintenance of
the electronic reporting system prescription monitoring program as part of the assigned
duties and responsibilities of their employment, provided that access to data is limited to
the minimum amount necessary to carry out such duties and responsibilities, and subject
to the requirement of de-identification and time limit on retention of data specified in
subdivision 5, paragraphs (d) and (e);
    (7) federal, state, and local law enforcement authorities acting pursuant to a valid
search warrant;
    (8) personnel of the medical assistance program Minnesota health care programs
assigned to use the data collected under this section to identify recipients whose usage of
controlled substances may warrant restriction to a single primary care physician provider,
a single outpatient pharmacy, or and a single hospital; and
(9) personnel of the Department of Human Services assigned to access the data
pursuant to paragraph (h); and
(10) personnel of the health professionals services program established under section
214.31, to the extent that the information relates specifically to an individual who is
currently enrolled in and being monitored by the program, and the individual consents to
access to that information. The health professionals services program personnel shall not
provide this data to a health-related licensing board or the Emergency Medical Services
Regulatory Board, except as permitted under section 214.33, subdivision 3.
    For purposes of clause (3) (4), access by an individual includes persons in the
definition of an individual under section 13.02.
    (c) Any A permissible user identified in paragraph (b), who clauses (1), (2), (5), (6),
and (8) may directly accesses access the data electronically,. If the data is directly accessed
electronically, the permissible user shall implement and maintain a comprehensive
information security program that contains administrative, technical, and physical
safeguards that are appropriate to the user's size and complexity, and the sensitivity of the
personal information obtained. The permissible user shall identify reasonably foreseeable
internal and external risks to the security, confidentiality, and integrity of personal
information that could result in the unauthorized disclosure, misuse, or other compromise
of the information and assess the sufficiency of any safeguards in place to control the risks.
    (d) The board shall not release data submitted under this section subdivision 4 unless
it is provided with evidence, satisfactory to the board, that the person requesting the
information is entitled to receive the data.
    (e) The board shall not release the name of a prescriber without the written consent
of the prescriber or a valid search warrant or court order. The board shall provide a
mechanism for a prescriber to submit to the board a signed consent authorizing the release
of the prescriber's name when data containing the prescriber's name is requested.
    (f) (e) The board shall maintain a log of all persons who access the data for a period
of at least three years and shall ensure that any permissible user complies with paragraph
(c) prior to attaining direct access to the data.
(g) (f) Section 13.05, subdivision 6, shall apply to any contract the board enters into
pursuant to subdivision 2. A vendor shall not use data collected under this section for
any purpose not specified in this section.
(h) (g) With available appropriations, the commissioner of human services shall
establish and implement a system through which the Department of Human Services shall
routinely access the data for the purpose of determining whether any client enrolled in
an opioid treatment program licensed according to chapter 245A has been prescribed or
dispensed a controlled substance in addition to that administered or dispensed by the
opioid treatment program. When the commissioner determines there have been multiple
prescribers or multiple prescriptions of controlled substances, the commissioner shall:
(1) inform the medical director of the opioid treatment program only that the
commissioner determined the existence of multiple prescribers or multiple prescriptions of
controlled substances; and
(2) direct the medical director of the opioid treatment program to access the data
directly, review the effect of the multiple prescribers or multiple prescriptions, and
document the review.
If determined necessary, the commissioner of human services shall seek a federal waiver
of, or exception to, any applicable provision of Code of Federal Regulations, title 42, part
2.34 , item (c), prior to implementing this paragraph.
    Subd. 7. Disciplinary action. (a) A dispenser who knowingly fails to submit data to
the board as required under this section is subject to disciplinary action by the appropriate
health-related licensing board.
    (b) A prescriber or dispenser authorized to access the data who knowingly discloses
the data in violation of state or federal laws relating to the privacy of health care data
shall be subject to disciplinary action by the appropriate health-related licensing board,
and appropriate civil penalties.
    Subd. 8. Evaluation and reporting. (a) The board shall evaluate the prescription
electronic reporting system to determine if the system is negatively impacting appropriate
prescribing practices of controlled substances. The board may contract with a vendor to
design and conduct the evaluation.
    (b) The board shall submit the evaluation of the system to the legislature by July
15, 2011.
    Subd. 9. Immunity from liability; no requirement to obtain information. (a) A
pharmacist, prescriber, or other dispenser making a report to the program in good faith
under this section is immune from any civil, criminal, or administrative liability, which
might otherwise be incurred or imposed as a result of the report, or on the basis that the
pharmacist or prescriber did or did not seek or obtain or use information from the program.
    (b) Nothing in this section shall require a pharmacist, prescriber, or other dispenser
to obtain information about a patient from the program, and the pharmacist, prescriber,
or other dispenser, if acting in good faith, is immune from any civil, criminal, or
administrative liability that might otherwise be incurred or imposed for requesting,
receiving, or using information from the program.
    Subd. 10. Funding. (a) The board may seek grants and private funds from nonprofit
charitable foundations, the federal government, and other sources to fund the enhancement
and ongoing operations of the prescription electronic reporting system monitoring
program established under this section. Any funds received shall be appropriated to the
board for this purpose. The board may not expend funds to enhance the program in a way
that conflicts with this section without seeking approval from the legislature.
(b) Notwithstanding any other section, the administrative services unit for the
health-related licensing boards shall apportion between the Board of Medical Practice, the
Board of Nursing, the Board of Dentistry, the Board of Podiatric Medicine, the Board of
Optometry, the Board of Veterinary Medicine, and the Board of Pharmacy an amount to
be paid through fees by each respective board. The amount apportioned to each board
shall equal each board's share of the annual appropriation to the Board of Pharmacy
from the state government special revenue fund for operating the prescription electronic
reporting system monitoring program under this section. Each board's apportioned share
shall be based on the number of prescribers or dispensers that each board identified in
this paragraph licenses as a percentage of the total number of prescribers and dispensers
licensed collectively by these boards. Each respective board may adjust the fees that the
boards are required to collect to compensate for the amount apportioned to each board by
the administrative services unit.

    Sec. 2. Minnesota Statutes 2012, section 214.32, is amended to read:
214.32 PROGRAM OPERATIONS AND RESPONSIBILITIES.
    Subdivision 1. Management. (a) A Health Professionals Services Program
Committee is established, consisting of one person appointed by each participating
board, with each participating board having one vote. no fewer than three, or more than
six, executive directors of health-related licensing boards or their designees, and two
members of the advisory committee established in paragraph (d). Program committee
members from the health-related licensing boards shall be appointed by a majority vote
of the executive directors of the health-related licensing boards in July of odd-numbered
years. Members from the advisory committee shall be appointed by a majority vote of
advisory committee members in July of odd-numbered years. The program committee
shall designate one board to provide administrative management of the program, set the
program budget and the pro rata share of administrative costs under paragraph (b) and
program expenses to be borne by each participating board, set the program budget, and
ensure the program is meeting its statutory charge. The program committee shall establish
uniform criteria and procedures governing termination and discharge for all health
professionals served by the health professionals services program.
    (b) The commissioner of administration shall provide guidance on the general
operation of the program, including hiring of program personnel, and ensure that the
program's direction is in accord with its authority. If the participating boards change
which board is designated to provide administrative management of the program, any
appropriation remaining for the program shall transfer to the newly designated board on
the effective date of the change. The participating boards must inform the appropriate
legislative committees and the commissioner of management and budget of any change
in the administrative management of the program, and the amount of any appropriation
transferred under this provision.
    (b) (c) The designated board, upon recommendation of the Health Professional
Services Program Committee, shall hire the program manager and employees and pay
expenses of the program from funds appropriated for that purpose. The designated board
may apply for grants to pay program expenses and may enter into contracts on behalf of
the program to carry out the purposes of the program. The participating boards shall enter
into written agreements with the designated board.
    (c) (d) An advisory committee is established to advise the program committee
consisting of:
    (1) one member appointed by each of the following: the Minnesota Academy of
Physician Assistants, the Minnesota Dental Association, the Minnesota Chiropractic
Association, the Minnesota Licensed Practical Nurse Association, the Minnesota Medical
Association, the Minnesota Nurses Association, and the Minnesota Podiatric Medicine
Association of the professional associations whose members are eligible for health
professionals services program services; and
    (2) one member appointed by each of the professional associations of the other
professions regulated by a participating board not specified in clause (1); and
    (3) (2) two public members, as defined by section 214.02.
    Members of the advisory committee shall be appointed for two years and members
may be reappointed.
    Subd. 2. Services. (a) The program shall provide the following services to program
participants:
(1) referral of eligible regulated persons to qualified professionals for evaluation,
treatment, and a written plan for continuing care consistent with the regulated person's
illness. The referral shall take into consideration the regulated person's financial resources
as well as specific needs;
(2) development of individualized program participation agreements between
participants and the program to meet the needs of participants and protect the public. An
agreement may include, but need not be limited to, recommendations from the continuing
care plan, practice monitoring, health monitoring, practice restrictions, random drug
screening, support group participation, filing of reports necessary to document compliance,
and terms for successful completion of the regulated person's program; and
(3) monitoring of compliance by participants with individualized program
participation agreements or board orders.
(b) The program may develop services related to sections 214.31 to 214.37 for
employers and colleagues of regulated persons from participating boards.
    Subd. 3. Participant costs. Each program participant shall be responsible for
paying for the costs of physical, psychosocial, or other related evaluation, treatment,
laboratory monitoring, and random drug screens.
    Subd. 4. Eligibility. Admission to the health professional services program is
available to a person regulated by a participating board who is unable to practice with
reasonable skill and safety by reason of illness, use of alcohol, drugs, chemicals, or
any other materials, or as a result of any mental, physical, or psychological condition.
Admission in the health professional services program shall be denied to persons:
(1) who have diverted controlled substances for other than self-administration;
(2) who have been terminated from this or any other state professional services
program for noncompliance in the program, unless referred by a participating board or the
commissioner of health;
(3) currently under a board disciplinary order or corrective action agreement, unless
referred by a board;
(4) regulated under sections 214.17 to 214.25, unless referred by a board or by the
commissioner of health;
(5) accused of sexual misconduct; or
(6) (5) whose continued practice would create a serious risk of harm to the public.
    Subd. 5. Completion; voluntary termination; discharge. (a) A regulated person
completes the program when the terms of the program participation agreement are fulfilled.
(b) A regulated person may voluntarily terminate participation in the health
professionals service program at any time by reporting to the person's board which shall
result in the program manager making a report to the regulated person's board under
section 214.33, subdivision 3.
(c) The program manager may choose to discharge a regulated person from the
program and make a referral to the person's board at any time for reasons including but not
limited to: the degree of cooperation and compliance by the regulated person, the inability
to secure information or the medical records of the regulated person, or indication of other
possible violations of the regulated person's practice act. The regulated person shall be
notified in writing by the program manager of any change in the person's program status.
A regulated person who has been terminated or discharged from the program may be
referred back to the program for monitoring.
    Subd. 6. Duties of a health-related licensing board. (a) Upon receiving
notice from the program manager that a regulated person has been discharged due to
noncompliance or voluntary withdrawal, when the appropriate licensing board has
probable cause to believe continued practice by the regulated person presents an imminent
risk of harm, the licensing board shall temporarily suspend the regulated person's
professional license. The suspension shall take effect upon written notice to the regulated
person and shall specify the reason for the suspension.
(b) The suspension shall remain in effect until the appropriate licensing board
completes an investigation and issues a final order in the matter after a hearing.
(c) At the time it issues the suspension notice, the appropriate licensing board shall
schedule a disciplinary hearing to be held pursuant to the Administrative Procedure Act.
The regulated person shall be provided with at least 20 days' notice of any hearing held
pursuant to this subdivision. The hearing shall be scheduled to being no later than 60
days after issuance of the suspension order.

    Sec. 3. MINNESOTA TANF EXPENDITURES TASK FORCE.
    Subdivision 1. Establishment. The Minnesota TANF Expenditures Task Force is
established to analyze past temporary assistance for needy families (TANF) expenditures
and make recommendations as to which, if any, programs currently receiving TANF
funding should be funded by the general fund so that a greater portion of TANF funds
can go directly to Minnesota families receiving assistance through the Minnesota family
investment program under Minnesota Statutes, chapter 256J.
    Subd. 2. Membership; meetings; staff. (a) The task force shall be composed of the
following members who serve at the pleasure of their appointing authority:
(1) one representative of the Department of Human Services appointed by the
commissioner of human services;
(2) one representative of the Department of Management and Budget appointed by
the commissioner of management and budget;
(3) one representative of the Department of Health appointed by the commissioner
of health;
(4) one representative of the Local Public Health Association of Minnesota;
(5) two representatives of county government appointed by the Association of
Minnesota Counties, one representing counties in the seven-county metropolitan area
and one representing all other counties;
(6) one representative of the Minnesota Legal Services Coalition;
(7) one representative of the Children's Defense Fund of Minnesota;
(8) one representative of the Minnesota Coalition for the Homeless;
(9) one representative of the Welfare Rights Coalition;
(10) two members of the house of representatives, one appointed by the speaker and
one appointed by the minority leader; and
(11) two members of the senate, including one member of the minority party,
appointed according to the rules of the senate.
(b) Notwithstanding Minnesota Statutes, section 15.059, members of the task force
shall serve without compensation or reimbursement of expenses.
(c) The commissioner of human services must convene the first meeting of the
Minnesota TANF Expenditures Task Force by July 31, 2014. The task force must meet at
least quarterly.
(d) Staffing and technical assistance shall be provided within available resources by
the Department of Human Services, Children and Family Services Division.
    Subd. 3. Duties. (a) The task force must report on past expenditures of the TANF
block grant, including a determination of whether or not programs for which TANF funds
have been appropriated meet the purposes of the TANF program as defined under Code of
Federal Regulations, title 45, section 260.20, and make recommendations as to which,
if any, programs currently receiving TANF funds should be funded by the general fund.
In making recommendations on program funding sources, the task force shall consider
the following:
(1) the original purpose of the TANF block grant under Code of Federal Regulations,
title 45, section 260.20;
(2) potential overlap of the population eligible for the Minnesota family investment
program cash grant and the other programs currently receiving TANF funds;
(3) the ability for TANF funds, as appropriated under current law, to effectively help
the lowest-income Minnesotans out of poverty;
(4) the impact of past expenditures on families who may be eligible for assistance
through TANF;
(5) the ability of TANF funds to support effective parenting and optimal brain
development in children under five years old; and
(6) the role of noncash assistance expenditures in maintaining compliance with
federal law.
(b) In preparing the recommendations under paragraph (a), the task force shall
consult with appropriate Department of Human Services information technology staff
regarding implementation of the recommendations.
    Subd. 4. Report. (a) The task force must submit an initial report by November
30, 2014, on past expenditures of the TANF block grant in Minnesota to the chairs and
ranking minority members of the legislative committees with jurisdiction over health and
human services policy and finance.
(b) The task force must submit a final report by February 1, 2015, analyzing past
TANF expenditures and making recommendations as to which programs, if any, currently
receiving TANF funding should be funded by the general fund, including any phase-in
period and draft legislation necessary for implementation, to the chairs and ranking
minority members of the legislative committees with jurisdiction over health and human
services policy and finance.
    Subd. 5. Expiration. This section expires March 1, 2015, or upon submission of the
final report required under subdivision 4, whichever is earlier.